Houma, LANCT04433572Now EnrollingIRB Ready

Peripheral Artery Disease Clinical Trial in Houma, LA

Access cutting-edge peripheral artery disease treatment through this clinical trial at a research site in Houma. Study-provided care at no cost to qualified participants.

Sponsored by Mercator MedSystems, Inc.

Quick Self-Assessment

See if you qualify for this Houma location

Preparing your pre-screening questions...

Expert Care in Houma

Access peripheral artery disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related peripheral artery disease treatment provided free

Apply for This Houma Location

Check if you qualify for this peripheral artery disease clinical trial in Houma, LA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Houma

    Convenient for LA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Houma site if eligible
  4. 4Begin participation

About This Peripheral Artery Disease Study in Houma

A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the effect of Temsirolimus Perivascular Injection 0.1 mg/mL on the incidence of ischemia-driven major amputation, clinically driven target lesion revascularization, and clinically relevant target lesion occlusion after revascularization of lesions below the knee in patients with symptomatic Rutherford 3-5 peripheral artery disease. The primary safety endpoint will be gathered at 1-month post-index procedure. The primar

Sponsor: Mercator MedSystems, Inc.

Who Can Participate

Inclusion Criteria

Pre-procedural: 1. Participant has signed and dated informed consent, is capable of understanding the nature, significance and implications of the clinical trial, and is willing to comply with all study procedures and follow-up visits for the duration of the study. 2. Participant is male or female, aged 18 years or older. 3. If participant is female and of reproductive potential: agreement to use a highly effective contraception (abstinence is acceptable) for at least 90 days after study treatment. 4. Participant has severe claudication (Rutherford 3) or chronic limb-threatening ischemia (CLTI) (Rutherford 4-5) in the Target Limb. Angiographic/Procedural: 5. Participant has up to two de novo or restenotic Qualified Target Lesions meeting the following criteria, each based on the Investigator's visual assessment. Target Lesions should be considered separate if they are located in separate vessels (not in the same blood path) or have more than 10 cm intervening n

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Houma?

Yes, this clinical trial (NCT04433572) has an active research site in Houma, LA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Peripheral Artery Disease Treatment Options in Houma, LA

If you're searching for peripheral artery disease treatment options in Houma, LA, this clinical trial (NCT04433572) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Houma research site is actively enrolling participants for this clinical trial. You'll receive care from experienced peripheral artery disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all peripheral artery disease clinical trials near you to find additional studies recruiting in your area.

More Peripheral Artery Disease Trials in Houma, LA

See all peripheral artery disease clinical trials recruiting in Houma — not just this study.

Browse Peripheral Artery Disease Trials in Houma →

Browse More Trials by Condition

Peripheral Artery Disease TrialsPulmonary Embolism TrialsRheumatoid Arthritis TrialsAnkylosing Spondylitis TrialsPulmonary Hypertension TrialsAll Conditions →

Ready to Join in Houma?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Houma, LA